Granulocyte colony-stimulating factor (G-CSF)' and macrophage colony-stimulating factor (M-CSF) are members of hematopoietic growth factors for granulocytic cell lineage and monocytic cell lineage, respectively, which are clinically available for patients with leukopenia as recombinant human CSFs. There have been some reports about the proliferative effects of these CSFs on human hematopoietic cells (1, 2) , but the intranuclear mechanism of early signal response to these mitogenic stimuli remains unknown. Each CSF binds to its specific receptor on the surface ofhematopoietic cells (3, 4) . The CSF-receptor interaction triggers a complex and poorly understood cascade ofmolecular events in signal transduction pathways, eventually leading to the transcriptional activation of immediate early response genes within the nucleus.
A series ofstudies indicate that many ofthe protooncogeneencoded products play pivotal roles in signal transduction systems that regulate cell proliferation in response to growth factors (5-7). Among these growth-related genes, some immediate early response genes such as members of the jun family or the fos family have been recently shown to be transiently activated when quiescent cells are stimulated by serum or various growth factors (8) (9) (10) (11) (12) . C-jun, junB, and junD which share significant sequence homology are coexpressed in many tissues (13) (14) (15) (16) (17) , although the transcription of c-jun and junB may reveal different responses between various mitogenic stimuli and cell types (18, 19) . Recent studies indicated that these genes are not coordinately regulated in fibroblasts (20) and that junB functions as a negative regulator of genes activated by c-jun (20, 21) . These findings may suggest that each product of the c-jun and junB genes confers distinct regulation on different target genes.
Little is known about the response of the jun family genes to G-CSF or M-CSF in cellular proliferation. To investigate the molecular mechanism of proliferative action of G-CSF and M-CSF in human hematopoietic cells, we employed the human myeloid leukemia cells (NKM-1) coexpressing both distinct G-CSF receptors and M-CSF receptors in this study. It was previously shown that NKM-1 cells can proliferate in serum-free medium in response to the physiological concentration ofrecombinant human G-CSF or M-CSF in a dose-dependent manner, and also additively to both CSFs (22, 23) . We report that G-CSF and M-CSF induce junB transcripts, but not c-jun, in the proliferative stimulation of human CSF-responsive myeloid cells.
Methods
Cell culture. Human myeloid leukemia cells (NKM-l) were grown in RPMI 1640 medium (Gibco Laboratories, Grand Island, NY) supplemented with 10% fetal bovine serum (FBS) (Flow Laboratories, Stanmore, Australia), 100 U/ml penicillin, and 50 ,ug/ml streptomycin in 5% CO2 humidified atmosphere at 370C. After serum-deprived culture, NKM-I cells were incubated in RPMI 1640 containing 10 ,gg/ml human transferrin with either G-CSF, M-CSF, or FBS. No feature ofcell differentiation can be induced by G-CSF or M-CSF in these cells (22) . Flow cytometric analysis of the cell cycle based on DNA content was performed after propidium iodide (Sigma Chemical Co., St. Louis, MO) staining as described previously (22 was electrophoresed on a 1.2% formaldehyde-agarose gel and transferred to Hybond-N membrane (Amersham Corp., Arlington Heights, IL). Prehybridizations, hybridizations, and washings were carried out according to the manufacturer's manual. 32P-oligo-random-labeled probes used were the 1.8-kb BamHI/EcoRI fragment ofa human c-jun cDNA (10) (provided by Dr. R. Tjian, University ofCalifornia, Berkeley), the 0.45-kb NarI fragment ofa human junB cDNA (21) showed that quiescent population in the GO/GI resting phase of the cell cycle increased from 44.7 to 78.6% after 48 h ofincubation in the serum-deprived condition. The resting cells, then, resumed their cycle through G, into S phase after stimulating this serum-deprived culture with 10 ng/ml of G-CSF for an additional 24 h (Fig. 1 A) . Growth response curves using the MTT assay showed that the number of viable cells in serumfree RPMI 1640 containing 10 ,g/ml transferrin was progressively increasing for 4 d after G-CSF or M-CSF addition (Fig. 1  B) . These proliferative responses to CSFs were also demonstrated by [3H]thymidine incorporation. DNA synthesis was significantly increased after 24 h exposure to G-CSF or M-CSF (Fig. 1 C) . Treatment of quiescent, serum-starved NKM-1 cells with 50 ng/ml G-CSF or M-CSF resulted in a rapid, transient increase in the levels ofjunB mRNA and c-fos mRNA. As shown in Fig. 2 , Northern blot analysis reveals that the increase of junB mRNA occurred within 20 min of CSF stimulation and reached a peak of ninefold between 40 and 60 min, and declined gradually to the basal level ofuntreated cells. In contrast, c-jun exhibited little change above the basal level for several hours after CSF addition. JunD expression was constitutively observed at detectable levels even in the quiescent state and anytime after CSF stimulation. The protein products ofthe jun family genes form heterodimetric complexes with fos protein to make a higher DNA binding affinity (27) (28) (29) . Although c-fos mRNA was also present at low levels in untreated NKM-1 cells, it was rapidly induced and elevated to a peak of 14-fold between 20 and 40 min after CSF stimulation. The results of these gene responses were similar to those in both cases of G-CSF and M-CSF. In contrast, the stimulation ofquiescent cells with 10% FBS induced the activated expression of c-jun by sevenfold, in addition to the similar enhancement ofjunB and c-fos expression (Fig. 2) . This demonstrates that the mechanism of c-jun gene expression is not defective in NKM-1 cells and that the signal transduction systems to nuclear transcription factors are different between CSF and FBS stimuli. When exponentially proliferating cells in the medium containing 10% FBS were treated with G-CSF, no induction in c-jun, junB, and c-fos mRNAs was observed.
Transcriptional run-on assays in isolated nuclei from NKM-1 cells revealed the mechanism responsible for the induction ofthejunB gene expression by CSFs. Fig. 3 shows that G-CSF ofjunB transcripts, but the expression of c-jun mRNA was not identified at least for several hours after CSFs addition. The evidence that the stimulation of quiescent NKM-1 cells with FBS activated cjun expression indicates that the signal transduction system to the c-jun gene and the mechanism of cjun expression are not impaired in these cells. It suggests that the signals of serum stimulation are pleiotropic and different from the proliferative signals of purified recombinant G-CSF or M-CSF. A second peak of c-jun expressed at the G,/S border in human fibroblasts (34) has not been determined in NKM-1 cells stimulated by CSFs, but it was reported to be different from response to receptor-generated signal'and coupled to the time ofentry to S phase. These results suggest that the receptorgenerated signal activating c-jun expression might be not required for the proliferative action of G-CSF and M-CSF and that junB may be not sufficient but involved in the mechanism of hemaitopoietic cell proliferation by these CSFs. These findings will provide a basis for investigating the molecular mechanism of action of G-CSF and M-CSF in human hematopoietic cells. Further investigation is needed concerning what role the products of the jun genes play in mediating' the action of G-CSF and M-CSF and in stimulating the cellular proliferation.
Discussion
The recent availability of cloned DNA probes for a variety of cellular response genes has made it possible to examine the transcriptional events resulting from growth factor stimulation. Immediate early response genes such as members of the jun family or the fos family have been reported to be induced in different cell types by serum or a variety of growth factors (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) . There is, however, little known about the regulation of these genes by hematopoietic colony-stimulating factors, G-CSF and M-CSF, since there have been very few human hematopoietic cell lines which can proliferate in response to these CSFs.
A recent report indicated that M-CSF induced c-jun expression with prolonged expression of the junB gene in human monocytes, but the induction ofboth c-jun and junB was associated with activation to a more differentiated monocytic phenotype (19) . It suggests that both'c-jun and junB expressions similar to those in other models of monocytic differentiation by chemical agents (30) should be definitely distinct from junB expression without cjun in M-CSF-stimulated proliferation. Another reported that in the mouse 3T3 cells transformed by a human CSF-I receptor (c-fms) mutant gene, the expression of junB was induced after M-CSF stimulation but no mitogenic response was observed (31) . 'It appears that the signal transduction system ofmitogenic response through receptors to nuclear transcription factors should be very complex and concerted. Even though junB is activated, cells could not proliferate when another component of the responsive orchestration in the signal transduction system was dysfunctional because of the mutation of receptors (32) .
It was recently reported that all three of anti-jun family antibodies prevented serum-stimulated DNA synthesis in 3T3 fibroblasts (33) . In our experiment using an established human myeloid leukemia cell line, NKM-1, which can proliferate in response to G-CSF or M-CSF, the proliferative stimulation of NKM-1 cells with these CSFs was in parallel with the induction
